Breathe
easy
Elevating customer
service to
patient care with
test-to-treat solutions
Navigate this respiratory
season with Sofia™ 2 Analyzer
Delivering accurate, objective and
automated results in as few as
3 to 15 minutes.
Revolutionizing rapid diagnostics
Act fast this flu
season – explore our
rapid solutions
*Sofia 2 SARS Antigen+ FIA received De Novo FDA clearance on
March 8, 2023 and CLIA waiver from the FDA on September 21, 2023.
New QuidelOrtho branding may not be available in all markets,
subject to country-specific regulatory approval. Please confirm
with your local commercial team.
PR-108707-NA-EN-US-v1
© 2025 QuidelOrtho Corporation. All rights reserved.
Sofia 2 respiratory assays
• RSV
• Influenza A+B
• Flu + SARS Antigen
• SARS Antigen
• Strep A+
• Sofia 2 SARS Antigen+ FIA is the first FDA-cleared,
10-minute rapid antigen test for COVID-19*